Dr Kayla Ann Grint, DVM, DACVIM | |
2465 N Main Street, Sunset, UT 84015 | |
(801) 776-8118 | |
Not Available |
Full Name | Dr Kayla Ann Grint |
---|---|
Gender | Female |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 2465 N Main Street, Sunset, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457829517 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 10968900-2801 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kayla Ann Grint, DVM, DACVIM 2465 N Main Street, Sunset, UT 84015 Ph: (801) 776-8118 | Dr Kayla Ann Grint, DVM, DACVIM 2465 N Main Street, Sunset, UT 84015 Ph: (801) 776-8118 |
News Archive
The National Academy of Medicine today announced Daniel Weinberger is the recipient of the 2019 Rhoda and Bernard Sarnat International Prize in Mental Health, for his fundamental role in elucidating the biological origins and genetic expressions of schizophrenia, and for transforming how clinicians, researchers, and the public understand mental illness.
A new study published in The British Medical Journal by researchers including SFU health sciences professor Scott Lear found consuming a high number of refined grains, such as croissants and white bread, is associated with a higher risk of major cardiovascular disease, stroke and death.
Regulation of a family of brain proteins known as bromodomain and extra-terminal domain containing transcription regulators (BETs) plays a key role in normal cognition and behavior, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published advanced online on September 21 and in print October 19 in The Journal of Experimental Medicine.
Researchers in the Vanderbilt University Institute of Imaging Science (VUIIS) have achieved the first conclusive non-invasive measurement of neural signaling in the spinal cords of healthy human volunteers.
Scientists are reporting discovery of a protein in the blood of lung cancer patients that could be used in a test for the disease - difficult to diagnose in its earliest and most treatable stages - and to develop drugs that stop lung cancer from spreading. Their study appears in ACS's Journal of Proteome Research.
› Verified 6 days ago